×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
Registration has been closed for this forum.
This forum will be conducted in Japanese Language only.
Program Committee
-
Noriko Katori, PhD Division of Drugs
National Institute of Health Sciences, Japan -
Takeshi Hamaura, PhD Head of Pharmaceutical Technology Division
Daiichi Sankyo Co., Ltd., Japan -
Yukio Hiyama, PhD Visiting Researcher
National Institute of Health Sciences, Japan -
Fusashi Ishikawa, PhD, MSc Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan -
Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Sachi Nakane Associate Manager, Research and Development Japan,
Bayer Yakuhin, Ltd., Japan -
Tomoaki Sakamoto, PhD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan -
Satomi Yagi Reviewer, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mio Yamazaki CMC RA Dept., Regulatory Affairs, Global Medical
GlaxoSmithKline K.K., Japan
Have an account?